Original Query: ALL
Previous Study | Return to List | Next Study

CS-7017 in Combination With Erlotinib in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01199068
Recruitment Status : Completed
First Posted : September 10, 2010
Last Update Posted : December 22, 2011
ICON Clinical Research
Information provided by (Responsible Party):
Daiichi Sankyo, Inc. ( Daiichi Sankyo Co., Ltd. )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2011
  Study Completion Date : December 2011